| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $70K | +107.5% | +47.1% |
| Cost of Revenue | $51K | +199.9% | -67.7% |
| R&D Expense | $5.3M | +166.7% | +88.0% |
| SG&A Expense | $3.2M | -10.4% | +22.2% |
| Operating Income | -$8.4M | -53.0% | -52.8% |
| Income Tax | $0 | — | — |
| Net Income | -$8.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.8M | -84.6% | — |
| Short-term Investments | $30.1M | +280.8% | +3597.9% |
| Accounts Receivable | $206K | +101.1% | — |
| Inventory | $886K | -10.2% | +135.8% |
| Current Assets | $39.1M | -10.4% | +778.0% |
| Total Assets | $49.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.8M | — | — |
| Capital Expenditures | $872K | — | — |
| Investing Cash Flow | -$31.6M | — | — |
| Financing Cash Flow | $29.6M | — | — |
| Free Cash Flow | -$17.7M | — | — |
| -55.5% |
| EPS (Basic) | -$1.20 | +55.6% | +56.2% |
| EPS (Diluted) | -$1.20 | +55.6% | +56.2% |
| -12.3% |
| +480.9% |
| Current Liabilities | $3.9M | +30.4% | +113.5% |
| Total Liabilities | $10.6M | +12.4% | +478.0% |
| Stockholders' Equity | $38.7M | -17.3% | +481.7% |